| Product Code: ETC7538024 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Bacteriophages Therapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Bacteriophages Therapy Market - Industry Life Cycle |
3.4 India Bacteriophages Therapy Market - Porter's Five Forces |
3.5 India Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 India Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 India Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant bacterial infections in India |
4.2.2 Rising awareness about the benefits of bacteriophages therapy as an alternative to antibiotics |
4.2.3 Government initiatives to promote research and development in the field of bacteriophages therapy |
4.3 Market Restraints |
4.3.1 Limited regulatory framework for bacteriophages therapy in India |
4.3.2 Lack of standardized manufacturing processes for bacteriophages products |
4.3.3 Limited availability of bacteriophages therapy in rural areas |
5 India Bacteriophages Therapy Market Trends |
6 India Bacteriophages Therapy Market, By Types |
6.1 India Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 India Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 India Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 India Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 India Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 India Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 India Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 India Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 India Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 India Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 India Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 India Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 India Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 India Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 India Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 India Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 India Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 India Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 India Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 India Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 India Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 India Bacteriophages Therapy Market Export to Major Countries |
7.2 India Bacteriophages Therapy Market Imports from Major Countries |
8 India Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted for bacteriophages therapy in India |
8.2 Adoption rate of bacteriophages therapy by healthcare providers |
8.3 Investment in research and development for bacteriophages products |
8.4 Patient outcomes and success rates of bacteriophages therapy |
8.5 Availability and accessibility of bacteriophages therapy in different regions of India |
9 India Bacteriophages Therapy Market - Opportunity Assessment |
9.1 India Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 India Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 India Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Bacteriophages Therapy Market - Competitive Landscape |
10.1 India Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 India Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here